Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C45H53NO14.2H2O |
| Molecular Weight | 867.9312 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.[H][C@@]12C[C@@]13C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]6(CO[C@]6([H])C2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C7=CC=CC=C7
InChI
InChIKey=SEFGUGYLLVNFIJ-QDRLFVHASA-N
InChI=1S/C45H53NO14.2H2O/c1-23-29(57-39(52)33(49)32(26-15-11-9-12-16-26)46-40(53)60-41(4,5)6)21-45(54)37(58-38(51)27-17-13-10-14-18-27)35-43(36(50)34(56-24(2)47)31(23)42(45,7)8)20-28(43)19-30-44(35,22-55-30)59-25(3)48;;/h9-18,28-30,32-35,37,49,54H,19-22H2,1-8H3,(H,46,53);2*1H2/t28-,29+,30-,32+,33-,34-,35+,37+,43-,44+,45-;;/m1../s1
LAROTAXEL is a taxoid with potential antineoplastic activity. It prevents microtubule depolymerization, thereby inhibiting cell proliferation. It displays a broad spectrum of antitumor activity in vitro and in vivo, including activity against P-glycoprotein expressing tumors. LAROTAXEL was in phase III clinical trials for the treatment of breast cancer, pancreatic cancer, and bladder cancer. However, its development was discontinued.
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Preclinical evaluation of new taxoids. | 2001 Sep |
|
| Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy. | 2008 Jul |
|
| Larotaxel: broadening the road with new taxanes. | 2009 Aug |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6918259
Created by
admin on Fri Dec 15 15:42:45 GMT 2023 , Edited by admin on Fri Dec 15 15:42:45 GMT 2023
|
PRIMARY | |||
|
23K148PYZO
Created by
admin on Fri Dec 15 15:42:45 GMT 2023 , Edited by admin on Fri Dec 15 15:42:45 GMT 2023
|
PRIMARY | |||
|
DTXSID80172850
Created by
admin on Fri Dec 15 15:42:45 GMT 2023 , Edited by admin on Fri Dec 15 15:42:45 GMT 2023
|
PRIMARY | |||
|
192573-38-9
Created by
admin on Fri Dec 15 15:42:45 GMT 2023 , Edited by admin on Fri Dec 15 15:42:45 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
